Bristol Myers Squibb
Jun 18, 2011 at 15:17 | Source: CNBC-TV18
Oct 27, 2010 at 08:14 | Source: Reuters
Oct 18, 2010 at 19:14 | Source: CNBC-TV18
Oct 09, 2010 at 11:13 | Source: Reuters
Oct 07, 2010 at 08:24 | Source: Reuters
Interact & exchange stock tips & market info »
Related News »
Tick-tock, tick-tock, tick-tock ... It was only a matter of time before Plavix, Bristol-Myers Squibb's best-selling blood-clot-fighting drug, was set to lose patent protection. Well, folks, that day has come and gone as of last Thursday, and one ...
May 20, 2012 at 15:55 | Source: msnbc.com
Bristol-Myers Squibb Company (NYSE: BMY - News) today announced that the company will present 18 abstracts on ORENCIA ® (abatacept) at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology in Berlin, June 6-9.
May 25, 2012 at 18:41 | Source: Yahoo Finance
For more than 80 years, as University Medical Center at Princeton, a respected teaching hospital, was expanding and evolving, one constant was the presence of a Clinic providing free or low-cost care to central New Jersey residents who need it.
May 22, 2012 at 19:20 | Source: Packet Online
Bristol-Myers Squibb Company (BMS) discovers, develops, licenses, manufactures and markets biopharmaceuticals and related healthcare products. It principally offers products in the fields of cancer, infectious diseases, psychiatry disorders, diabetes ...
May 20, 2012 at 18:11 | Source: Transworld News
The Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes ® initiative to China and India, pledging $15 million over five years to help these developing nations with rapidly growing numbers of type 2 diabetes ...
May 25, 2012 at 22:01 | Source: Yahoo Finance
Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial production of ORENCIA ® (abatacept).
May 16, 2012 at 08:43 | Source: News-Medical.Net
PARIS, May 14, 2012 /PRNewswire via COMTEX/ -- Results of head-to-head study comparing two biologic drugs on a background of methotrexate for the treatment of moderate to severe rheumatoid arthritis to be presented Bristol-Myers Squibb Company ...
May 14, 2012 at 11:52 | Source: Marketwatch
SHANGHAI, China, May 15, 2012 (BUSINESS WIRE) -- The Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes(R) initiative to China and India, pledging $15 million over five years to help these developing nations with ...
May 15, 2012 at 13:59 | Source: CNBC
- Results of head-to-head study comparing two biologic drugs on a background of methotrexate for the treatment of moderate to severe rheumatoid arthritis to be presented Bristol-Myers Squibb Company [http://www.bms.com] today announced that the company ...
May 14, 2012 at 12:49 | Source: PressePortal.de
NEW YORK, May 15, 2012 (BUSINESS WIRE) -- Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial ...
May 15, 2012 at 14:57 | Source: CNBC